Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application

Toll-like receptor 9 (TLR9) is expressed in a variety of B-cell malignancies and works as a bridge between innate and adaptive immunity. CpG oligodeoxynucleotides (CpG ODNs), TLR9 agonists, are able to induce anticancer immune responses and exert direct effects against cancer cells, serving as cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Ling, Chen, Wei, Chen, Jingtao, Li, Wei, Zhou, Lei, Niu, Chao, Han, Wei, Cui, Jiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329966/
https://www.ncbi.nlm.nih.gov/pubmed/28241765
http://dx.doi.org/10.1186/s12967-017-1152-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329966/
https://www.ncbi.nlm.nih.gov/pubmed/28241765
http://dx.doi.org/10.1186/s12967-017-1152-5

Ejemplares similares